🔗 Share this article

An underground economy for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.

Investigational Drug Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these accounts privately for supplier links, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with numerous of members share “before and after” photos, injection guides and assertions of rapid British shipping. Vendors market the drug there before directing customers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Experts Voice Worries

However, physicians and chemists have cautions that the distribution of what remains an unlicensed drug in the UK is worrisome and could lead to users administering products of unknown origin.

Some professionals said the popularity for the experimental drug could be connected to the rising cost of approved slimming products such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the British medical regulations.

Some influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate medicines, advertising, and customer regulations, potentially leading to fines, legal action or imprisonment.

Service Reaction and Material Elimination

According to the social media company, the service has removed problematic content and banned related keywords and search suggestions. The organization said it was dedicated to maintaining the platform secure and allocating resources in strengthening enforcement strategies.

Digital Trading Activities

Research also found groups with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays channels with thousands of members, filled with photos of weight loss, positive reviews and step-by-step guides for mixing or injecting at home.

After minutes of entering one community, a seller shared contact information, where most transactions take place. The seller sent an guidebook and guaranteed shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about body mass, medical conditions or previous experience.

Product Details and Pricing

Within these groups, messages show black plastic packages with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with sterile water, or pre-filled injectors usually sold at 160 pounds for 20 milligrams. When asked how long a pen should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A representative for Telegram said it regularly monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering substances they can’t verify. Even if the science behind this drug is sound, these digital versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to social media. But fake treatments are extremely risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.

Her staff has previously encountered individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly investigational product not yet authorized … may expose patients to possibly serious medical dangers”.